Introduction: Multimorbidity is a major challenge for current healthcare systems and professionals. From the different approaches that have been proposed to analyse this issue, the hypothesis of the existence of association patterns of different chronic conditions is gaining visibility. In addition, multimorbidity can be associated to polypharmacy, which can lead to a higher risk of potentially inappropriate prescribing (PIP) and consequently to adverse drug reactions (ADRs). The general objective of this novel study is to identify the association between PIP, multimorbidity patterns, polypharmacy and the presence of ADRs in older patients admitted for exacerbation of chronic diseases. Methods and analysis: The MoPIM (morbidity, potentially...
Multimorbidity is a global health challenge that is associated with polypharmacy, increasing the ris...
Aim: To measure the extent of polypharmacy, multimorbidity and potential medication-related problems...
Background Multimorbidity is a global health challenge that is associated with polypharmacy, increas...
Multimorbidity is a major challenge for current healthcare systems and professionals. From the diffe...
ObjectivesThe objective was to identify the systematic associations among chronic diseases and drugs...
OBJECTIVES: The objective was to identify the systematic associations among chronic diseases and dr...
OBJECTIVES: The objective was to identify the systematic associations among chronic diseases and dr...
OBJECTIVES: The objective was to identify the systematic associations among chronic diseases and dr...
(1) Background: The acquisition of multiple chronic diseases, known as multimorbidity, is common in ...
Objectives: The objectives of the present analyses are to estimate the frequency of potentially inap...
Objectives: The objective was to identify the systematic associations among chronic diseases and dru...
(1) Introduction: Cardiovascular disease is associated with high mortality, especially in older peop...
Altres ajuts: Pla Estratègic de Recerca i Innovació en Salut (PERIS), SLT002/16/00058Background: The...
Background Multimorbidity is a global health challenge that is associated with polypharmacy, increas...
Altres ajuts: Pla Estratègic de Recerca i Innovació en Salut (PERIS), SLT002/16/00058Background: The...
Multimorbidity is a global health challenge that is associated with polypharmacy, increasing the ris...
Aim: To measure the extent of polypharmacy, multimorbidity and potential medication-related problems...
Background Multimorbidity is a global health challenge that is associated with polypharmacy, increas...
Multimorbidity is a major challenge for current healthcare systems and professionals. From the diffe...
ObjectivesThe objective was to identify the systematic associations among chronic diseases and drugs...
OBJECTIVES: The objective was to identify the systematic associations among chronic diseases and dr...
OBJECTIVES: The objective was to identify the systematic associations among chronic diseases and dr...
OBJECTIVES: The objective was to identify the systematic associations among chronic diseases and dr...
(1) Background: The acquisition of multiple chronic diseases, known as multimorbidity, is common in ...
Objectives: The objectives of the present analyses are to estimate the frequency of potentially inap...
Objectives: The objective was to identify the systematic associations among chronic diseases and dru...
(1) Introduction: Cardiovascular disease is associated with high mortality, especially in older peop...
Altres ajuts: Pla Estratègic de Recerca i Innovació en Salut (PERIS), SLT002/16/00058Background: The...
Background Multimorbidity is a global health challenge that is associated with polypharmacy, increas...
Altres ajuts: Pla Estratègic de Recerca i Innovació en Salut (PERIS), SLT002/16/00058Background: The...
Multimorbidity is a global health challenge that is associated with polypharmacy, increasing the ris...
Aim: To measure the extent of polypharmacy, multimorbidity and potential medication-related problems...
Background Multimorbidity is a global health challenge that is associated with polypharmacy, increas...